u/elin_ferrari

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

Are we talking 503A or 503B?

I am going to push back on this slightly.

Every time this gets posted it hits the front page and every time someone has to re-explain it.

dosing errors come from people reconstituting two vials differently and forgetting which is which

Yes, exactly this, and it is the bit that took me 11 weeks to accept.

This is correct. The shortage list does expire and the rules change.

rodent dual agonist is investigation only

This is correct. Variance is the story.

swirl, do not shake, or you are courting oxidation

This is correct. 2mL versus 15mL is the common mistake.

receipts or nothing, sorry but that is the rule

SURMOUNT data is messier than STEP data but the weight loss is there

no pharmacy referral codes, naming is fine, recruiting is not

Adding to this: 503B is doing more work than the comment implies.

transit time variance is the story, not the average

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

Cosigning the evidence standard. Receipts make the community.

no pharmacy referral codes, naming is fine, recruiting is not

the GLP-1/glucagon dual is hepatic fat, different from GIP/GLP-1

The single most useful thing I did was write the concentration on the vial. Stopped all the confusion after that.